ロード中...
Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer
BACKGROUND: Bevacizumab has become standard of care as first-line treatment of metastatic colorectal cancer (mCRC), after proving increased response rates and improvement in survival outcomes. Hypertension (HTN) is a common complication of the treatment with bevacizumab and, owing to its close relat...
保存先:
| 出版年: | ESMO Open |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070256/ https://ncbi.nlm.nih.gov/pubmed/27843607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000045 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|